Scientific Analysis of Ginkgo Flavonoids and Terpenoids: How to Maximize the Bioavailability of Extracts?

Scientific Analysis of Ginkgo Flavonoids and Terpenoids: How to Maximize the Bioavailability of Extracts?

Abstract

Ginkgo Biloba Extract(GBE), rich in bioactive compounds such as ginkgo flavonoids (e.g., quercetin, kaempferol) and terpenoids (e.g., ginkgolides A, B, and bilobalide), has demonstrated significant antioxidant, anti-inflammatory, and neuroprotective effects. Blue Eyes Biotech CO., Ltd employs advanced extraction and formulation technologies to enhance the bioavailability of its GinkgoPrime™ extract, setting a new industry standard.  

Key Active Components

Flavonoids scavenge free radicals, while terpenoids (e.g., Ginkgolide B) inhibit platelet-activating factor (PAF), improving microcirculation. Conventional extraction methods often compromise potency. Blue Eyes Biotech CO., Ltd utilizes patented low-temperature extraction (Patent No.: BE-2023-GK01) to ensure GinkgoPrime™ contains ≥24% flavonoids and ≥6% terpenoids while preserving molecular integrity.  

Bioavailability Enhancement Strategies

Nano-encapsulation:

Liposomal delivery systems in

Synergistic formulations:

Combining GinkgoFlex™ with phospholipids or cyclodextrins minimizes gastric degradation. Clinical trials confirm Blue Eyes Biotech CO., Ltd's extracts achieve 40% higher bioavailability than conventional products.  

Applications

GinkgoPrime™ is utilized in cognitive support capsules (NeuroGinkgo®) and cardiovascular health solutions (CardioGinkgo®). Blue Eyes Biotech CO., Ltd offers customized GinkgoBio™ series for diverse therapeutic needs.  

Conclusion

Through innovative extraction and delivery systems, Blue Eyes Biotech CO., Ltd 's GinkgoPrime™, NeuroGinkgo®, and GinkgoFlex™ maximize therapeutic efficacy. For collaborations, contact **[email protected]** or visit **www.blueeyes-bio.com**.